Director · Amneal Pharmaceuticals, Inc. · Class A Common Stock
Side
G
Value
—
Shares
20.4K
Price
—
Executed
Sep 17, 2026
Disclosed
Sep 21, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Sep 17 executedSep 21, 2026 disclosed
AMRX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
No reported dollar value · 37.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · AMRX
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Buchi J Kevin filed this Form 4 reporting a gift of AMRX on Sep 17, 2026. It became public on Sep 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Buchi J Kevincik:0001209726
Issuer
Amneal Pharmaceuticals, Inc.cik:0001723128
Revision history · 0
No field has changed since this record was first ingested.
